BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21560107)

  • 1. [Positron emission tomography in tumors of the upper gastrointestinal tract: controversial value].
    Vallböhmer D; Hölscher AH
    Dtsch Med Wochenschr; 2011 May; 136(20):1060. PubMed ID: 21560107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
    Lordick F; Ott K; Krause BJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1061-6. PubMed ID: 21560108
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in gastric and esophageal cancer.
    Flamen P
    Curr Opin Oncol; 2004 Jul; 16(4):359-63. PubMed ID: 15187891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
    Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
    Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary.
    Low DE
    Ann Thorac Surg; 2008 Oct; 86(4):1138. PubMed ID: 18805148
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Mondaca S; Janjigian YY
    Cancer; 2019 Apr; 125(8):1214-1217. PubMed ID: 30668898
    [No Abstract]   [Full Text] [Related]  

  • 8. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
    Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
    N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed tomography in the staging of gastrointestinal carcinoma.
    Moss AA
    Radiol Clin North Am; 1982 Dec; 20(4):761-80. PubMed ID: 6758033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and PET-CT in esophageal and gastric cancer.
    Wieder HA; Krause BJ; Herrmann K
    Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 May; 19(6):775-8, 783-4, 788 passim. PubMed ID: 15971452
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
    Mönig SP; Berlth F; Chon SH
    Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
    [No Abstract]   [Full Text] [Related]  

  • 13. New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.
    Lordick F; Ott K; Krause BJ
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii294-9. PubMed ID: 20943631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal tract malignancies and positron emission tomography: an overview.
    Esteves FP; Schuster DM; Halkar RK
    Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplasms of the esophagus and stomach.
    Dehdashti F; Siegel BA
    Semin Nucl Med; 2004 Jul; 34(3):198-208. PubMed ID: 15202101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
    Smith JW; Moreira J; Abood G; Aranha GV; Nagda S; Wagner RH; Shoup M
    Am J Surg; 2009 Mar; 197(3):308-12. PubMed ID: 19245906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging of esophageal and gastric cancer in 2014.
    Yegin EG; Duman DG
    Minerva Med; 2014 Oct; 105(5):391-411. PubMed ID: 25000218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.
    Dam HQ; Manzone TM; Sagar VV
    Surg Oncol Clin N Am; 2006 Oct; 15(4):733-49. PubMed ID: 17030270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasms of the upper gastrointestinal tract.
    Trenkner SW; Halvorsen RA; Thompson WM
    Radiol Clin North Am; 1994 Jan; 32(1):15-24. PubMed ID: 8284355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.